Fabien Fillesoye

Publications

Article dans une revue (12)

Monitoring whole-body inflammation with gallium-68-labeled polydopamine iron oxide particles via hybrid immuno-PET-MRI Swannie Pedron,Amaury Guillou,Fabien Fillesoye,Charlène Jacqmarcq,Cécile Perrioet al. ACS Nano, 2025, 19 (33), pp.30021-30033. ⟨10.1021/acsnano.5c04677⟩ Article dans une revue hal-05400159v1
Evaluation of Specific Binding of [11C]RTI-97 to KOR by Autoradiog-raphy and PET Imaging in Rat Fabien Fillesoye,Méziane Ibazizene,Nicolas Marie,Florence Noble,Cécile Perrio ACS Medicinal Chemistry Letters, 2021, 12 (11), pp.1739-1744. ⟨10.1021/acsmedchemlett.1c00369⟩ Article dans une revue hal-03381883v1
Chemical Delivery System of MIBG to the Central Nervous System: Synthesis, 11 C-Radiosynthesis, and in Vivo Evaluation Fabienne Gourand,Delphine Patin,Axelle Henry,Meźiane Ibazizeǹe,Martine Dhillyet al. ACS Medicinal Chemistry Letters, 2019, 10 (3), pp.352-357. ⟨10.1021/acsmedchemlett.8b00642⟩ Article dans une revue hal-03020265v1
[ 18 F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [ 18 F]FDG in human xenograft models Narinée Hovhannisyan,Fabien Fillesoye,Stéphane Guillouet,Méziane Ibazizene,Jérôme Toutainet al. Theranostics, 2018, 8 (16), pp.4563-4573. ⟨10.7150/thno.26754⟩ Article dans une revue hal-02006576v1
Delivering FLT to the Central Nervous System by Means of a Promising Targeting System: Synthesis, [11C]Radiosynthesis, and in Vivo Evaluation Fabienne Gourand,Mihaela-Liliana Tîntas,Axelle Henry,Méziane Ibazizène,Martine Dhillyet al. ACS Chemical Neuroscience, 2017, 8 (11), pp.2457-2467. ⟨10.1021/acschemneuro.7b00218⟩ Article dans une revue hal-02046279v1
N-[18F]-FluoropropylJDTic for κ-opioid receptor PET imaging : Radiosynthesis, pre-clinical evaluation, and metabolic investigation in comparison with parent JDTic. S Schmitt,J Delamare,O Tirel,F Fillesoye,M Dhillyet al. Nuclear Medicine and Biology, 2017, 44, pp.50-61. ⟨10.1016/j.nucmedbio.2016.09.005⟩ Article dans une revue hal-01575523v1
[18F]Fludarabine-PET in a murine model of multiple myeloma N Hovhannisyan,M Dhilly,M Fidalgo,F Fillesoye,S Guillouetet al. PLoS ONE, 2017, 12 (5), pp.e0177125. ⟨10.1371/journal.pone.0177125⟩ Article dans une revue hal-01575068v1
Gallium-68 Complexes Conjugated to Pittsburgh Compound B: Radiolabeling and Biological Evaluation D Cressier,M Dhilly,Tt Cao Pham,F Fillesoye,F Gourandet al. Molecular Imaging and Biology, 2016, 18 (3), pp.334-43. ⟨10.1007/s11307-015-0906-9⟩ Article dans une revue hal-01575680v1
Evaluation of the specificity of [18F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [18F]FDG and impact of rituximab therapy N Hovhannisyan,S Guillouet,F Fillesoye,M Dhilly,D Patinet al. EJNMMI Research, 2015, 5, pp.23. ⟨10.1186/s13550-015-0101-7⟩ Article dans une revue hal-01577880v1
Chronic arterial hypertension impedes glioma growth: a multiparametric MRI study in the rat. Al Letourneur,S Roussel,M Bernaudin,F Fillesoye,J Toutainet al. Hypertension Research, 2015, 38 ((11)), pp.723-32. ⟨10.1038/hr.2015.66⟩ Article dans une revue hal-01587404v1
Effects of mesenchymal stem cell therapy, in association with pharmacologically active microcarriers releasing VEGF, in an ischaemic stroke model in the rat. Ms Quittet,O Touzani,L Sindji,J Cayon,F Fillesoyeet al. Acta Biomaterialia, 2015, 15, pp.77-88. ⟨10.1016/j.actbio.2014.12.017⟩ Article dans une revue hal-01577870v1
2-[18F]Fludarabine, a Novel Positron Emission Tomography (PET) Tracer for Imaging Lymphoma: a Micro-PET Study in Murine Models Martine Dhilly,Stéphane Guillouet,Delphine Patin,Fabien Fillesoye,Ahmed Abbaset al. Molecular Imaging and Biology, 2014, 16 (1), pp.118 - 126. ⟨10.1007/s11307-013-0659-2⟩ Article dans une revue hal-01599730v1

Communication dans un congrès (12)

Development and in vivo preclinical validation of [18F]FLUSONIM, a highly hydrophilic 18F-labelled 2-nitroimidazole derivative for high performance hypoxia PET imaging C. Maingueneau,A.-E. Lafargue,F. Fillesoye,J. Toutain,S. Valableet al. 4th Nuclear Technologies for Health Symposium, NTHS2020, Feb 2020, Nantes, France Communication dans un congrès hal-02489356v1
Vectorisation of [18F] radiotracers for brain tumors imaging M-L Tintas,A Henry,S Guillouet,M Ibazizène,M Dhillyet al. 5th World Congress & Expo on Pharmaceutics & Drug Delivery Systems, Feb 2020, Lisbonne, Portugal Communication dans un congrès hal-02489363v1
Synthesis and in vivo evaluation of new 2-nitroimidazole 18F-radiotracers for PET hypoxia imaging. C. Maingueneau,F. Fillesoye,Guillouet S,Perrio C Congrès SECO56, May 2019, La Clusaz, France Communication dans un congrès hal-02320376v1
Développement et validation préclinique in vivo du [18F]FLUSONIM pour l’imagerie TEP de l’hypoxie de haute performance Clémence Maingueneau,Anne-Élodie Lafargue,Fabien Fillesoye,Jérôme Toutain,Samuel Valableet al. Journées scientifiques du Cancéropôle Nord-Ouest, Dec 2019, Lille, France Communication dans un congrès hal-02414509v1
Sultone-based radiochemistry for the development of 18F-radiotracers for high performance hypoxia PET imaging Clémence Maingueneau,Anne-Élodie Lafargue,Fabien Fillesoye,Stéphane Guillouet,Cécile Perrio ISRS 2019, Jun 2019, Pékin, China Communication dans un congrès hal-02414491v1
Differentiation of CNS lymphoma and glioblastoma with [18F]fludarabine-PET: comparison with [18F]FDG in human xenograft models. N. Hovhannisyan,S. Guillouet,M. Dhilly,M. Ibazizene,F. Fillesoyeet al. 30th Annual Congress of the European Association of Nuclear Medicine, Oct 2017, Vienne, Austria Communication dans un congrès hal-02320446v1
[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analysis with [18F]FDG in human xenograft models. N. Hovhannisyan,S. Guillouet,M. Dhilly,M. Ibazizene,F. Fillesoyeet al. 2ème Congrès National d'Imagerie du Vivant CNIV 2017, Nov 2017, Paris, France Communication dans un congrès hal-02320429v1
18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analysis with [18F]FDG in human xenograft models N. Hovhannisyan,S. Guillouet,M. Dhilly,M. Ibazizene,F. Fillesoyeet al. Journée du Cancéropôle Nord-Ouest Axe 3 : "Imagerie Fonctionnelle et Radiothérapie”, Dec 2017, Caen, France Communication dans un congrès hal-02268076v1
Vectorisation cérébrale de la [18F]FLT pour l’imagerie de gliomes de bas grade. Ml. Tintas,S. Guillouet,M. Ibazizène,M. Dhilly,F. . Fillesoyeet al. 24th Young Research Fellow Meeting in Medicinal Chemistry, Feb 2017, Châtenay-Malabry, France Communication dans un congrès hal-02320458v1
JDTic-based radiotracers for Kappa Opioid Receptor PET Imaging: Design, Synthesis, Pharmacology, Molecular Modeling Studies, Radiolabelling, in vivo Characterization and Metabolic Investigation C. Perrio,S. Schmitt,J. Delamare,O. Tirel,M. Dhillyet al. EANM’16 29th Annual congress of the European Association of Nuclear Medicine, Oct 2016, Barcelone, Spain Communication dans un congrès hal-02325472v1
JDTic-based Radioligands for PET Imaging of Kappa Opioid Receptors: Design, Synthesis, Pharmacology, Molecular Modeling Studies, Radiolabelling with Carbon-11 or Fluorine-18, and in vivo Characterization S Schmitt,J Delamare,M Dhilly,O Tirel,F Fillesoyeet al. NTHS 2015, Mar 2015, Nantes, France Communication dans un congrès hal-02366099v1
Comparative analysis between [18F]Fludarabine- and [18F]FDG-PET in a murine model of inflammation M Dhilly,N Hovhannisyan,A Maiza,F Fillesoye,S Guillouetet al. 3rd Nuclear Technologies for Health Symposium, Mar 2015, Nantes, France Communication dans un congrès hal-02366172v1

Poster de conférence (8)

Transport into the central nervous system of [18F]FLT and [18F]Fludarabine for brain tumors M-L Tintas,S Guillouet,M Ibazizène,F Fillesoye,C Papamicaëlet al. 4th Nuclear Technologies for Health Symposium, NTHS2020, Feb 2020, Nantes, France Poster de conférence hal-02487617v1
Transport into the central nervous system of [18F]FLT and [18F]Fludarabine for brain tumors Mihaela-Liliana Tîntas,S Guillouet,Méziane Ibazizène,Fabien Fillesoye,C. Papamicaëlet al. 23rd International Symposium on Radiopharmaceutical Sciences, May 2019, Beijing, China Poster de conférence hal-02374599v1
[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analyses with [18F]FDG and [11C]MET in human xenograft models N Hovhannisyan,F Fillesoye,M Dhilly,S Guillouet,M Ibazizèneet al. ESMI, Mar 2018, San Sebastian, Spain Poster de conférence hal-02379585v1
CNS lymphoma imaging with [18F]fludarabine-PET: comparison with [18F]FDG in a human lymphoma xenograft model N Hovhannisyan,F Fillesoye,M Dhilly,S Guillouet,M Ibazizeneet al. WMIC, Sep 2017, Philadelphia, United States Poster de conférence hal-02386345v1
[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analysis with [18F]FDG in human xenograft models N Hovhannisyan,F Fillesoye,M Dhilly,S Guillouet,M Ibazizeneet al. JNRB CHU, Nov 2017, Caen, France Poster de conférence hal-02380577v1
Un nouveau radiotracer pour l’imagerie TEP de l’hypoxie à fort contraste et délai ultra-court : validation pré-clinique dans une modèle de sarcome C Maingueneau,A-E Lafargue,F Fillesoye,S Guillouet,L Barréet al. Réunion de l'Axe 3 du Cancéropôle Nord-Ouest, Dec 2017, Caen, France Poster de conférence hal-02370093v1
Microdose study of 11C radiolabeled Donecopride, a multi-target-directed ligand for Alzheimer’s disease treatment F. Fillesoye,M. Ibazizene,M. Dhilly,A. Maiza,P. Dallemagneet al. The 21th International Symposium on Radiopharmaceutical Sciences, May 2015, Columbia, United States. 58[Suppl. 1], pp.S302, J Label Compd Radiopharm Poster de conférence hal-02325009v1
JDTic-based Radiotracers for PET Imaging of Kappa Opioid Receptors: Design, Synthesis, Pharmacology, Molecular Modeling Studies, Radiolabelling with Carbon-11 or Fluorine-18, and in vivo Characterization S Schmitt,J Delamare,M Ibazizène,O Tirel,M Dhillyet al. Journées Neurosciences, Workshop FLI, Nov 2015, Orsay, France Poster de conférence hal-02386754v1